Mushroom antioxidant eases period pain in small trial

An antioxidant called L-ergothioneine, found in certain mushrooms, reduced period pain in a small study of 40 women. Participants took a daily 120-milligram supplement over three menstrual cycles, reporting lower pain scores compared to a placebo group. The findings suggest it targets oxidative stress in uterine cells.

Researchers led by Guohua Xiao at Gene III Biotechnology Co. in Nanjing, China, tested L-ergothioneine on women aged 18 to 30 with primary dysmenorrhea, a common cause of menstrual pain not linked to conditions like endometriosis. None had used painkillers or other treatments in the prior month. Half received 120 milligrams of the supplement daily for three cycles; the rest got a placebo. Initial pain scores averaged 4.8 out of 10, dropping to 4.1, 3.6 and 2.3 for the supplement group, with no notable change in the placebo group, according to a preprint on medRxiv (DOI: 10.64898/2026.03.26.26349375). No side effects were reported in either group. Xiao explained that L-ergothioneine accumulates in cells over time, potentially neutralizing free radicals in uterine tissue before inflammation escalates. “Instead of treating the symptom acutely when the pain is already severe, EGT acts as a nutritional foundational support, potentially reducing the reliance on strong medications,” Xiao said. The study found no difference in systemic inflammation levels between groups, supporting a localized antioxidant effect, Xiao added. Andrea Maier at the University of Melbourne called the mechanism biologically plausible but urged a larger trial for confirmation. Xiao's team plans a multi-center study to assess safety and efficacy further. Long-term painkiller use like ibuprofen carries risks including heart issues and kidney problems, unlike this supplement, which the kidneys excrete once saturated.

Related Articles

Scientific illustration depicting parathyroid hormone strengthening mouse vertebral endplates to repel pain nerves, reducing chronic low back pain in spinal degeneration models.
Image generated by AI

Study links parathyroid hormone to reduced chronic low back pain in mice by limiting abnormal nerve growth

Reported by AI Image generated by AI Fact checked

A study published in the journal *Bone Research* reports that parathyroid hormone (PTH) reduced pain-related behaviors in mouse models of spinal degeneration, apparently by strengthening vertebral endplates and triggering bone-cell signals that repel pain-sensing nerve fibers. The work was led by Dr. Janet L. Crane of Johns Hopkins University School of Medicine.

New research indicates that regular use of ibuprofen, a common painkiller, may reduce the risk of endometrial cancer by up to 25% in certain women. This finding comes from a large-scale study analyzing over 42,000 participants, highlighting the drug's anti-inflammatory properties. However, experts caution against using it for prevention due to potential side effects.

Reported by AI

Researchers at University College London have discovered how the body naturally shuts down inflammation using fat-derived molecules called epoxy-oxylipins. These molecules prevent the buildup of immune cells linked to chronic diseases like arthritis and heart disease. A study involving a drug that boosts these molecules showed faster pain relief and reduced harmful immune activity.

After 11 years of research, scientists at McMaster University have identified a molecule called butyrolactol A that weakens deadly fungi, making them vulnerable to existing treatments. This discovery targets pathogens like Cryptococcus neoformans, which pose severe risks to immunocompromised individuals. The finding could revive outdated antifungal drugs amid rising resistance.

Reported by AI

Gut bacteria that recycle oestrogens back into the bloodstream are far more abundant in people from industrialised societies than in hunter-gatherers and rural farmers, according to a new study. Researchers found up to seven times greater recycling capacity in urban populations. The findings raise questions about potential health impacts from elevated hormone levels.

An experimental therapy using stem cells from young donors has shown promise in improving mobility for frail older people. In a trial involving 148 participants, infusions of laromestrocel led to significant gains in walking distance. Researchers highlight its potential to address biological roots of frailty.

Reported by AI

A new study in Gastroenterology connects early life stress to long-term gut issues through disruptions in gut-brain communication. Mouse experiments and large human cohorts show links to pain, constipation, and irritable bowel syndrome. Researchers suggest targeted treatments based on specific biological pathways.

 

 

 

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline